We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Sector Composition

Rank Sector Weight
1 Technology 6.25%
2 Industrials 4.6%
3 Consumer Discretionary 4.31%
4 Healthcare 4.26%
5 Financials 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NMTR
5201
DELISTED
9 Meters Biopharma
NMTR
-9,431
Closed -$108K
NOVN
5202
DELISTED
Novan, Inc. Common Stock
NOVN
-1,867
Closed -$9K
MLVF
5203
DELISTED
Malvern Bancorp, Inc.
MLVF
-1,947
Closed -$25K
IMBI
5204
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
-3,841
Closed -$13K
BNSO
5205
DELISTED
Bonso Electronic International
BNSO
-19
Closed
BLCM
5206
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
-7,030
Closed -$52K
SIRE
5207
DELISTED
Sisecam Resources LP
SIRE
$0 ﹤0.01%
34
-7
-17% -$78
RIDE
5208
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
-34
Closed -$5K
OIG
5209
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
-739
Closed -$18K
CIH
5210
DELISTED
China Index Holdings Limited American Depository Shares
CIH
-100
Closed
NVCN
5211
DELISTED
Neovasc Inc.
NVCN
$0 ﹤0.01%
4
APEN
5212
DELISTED
Apollo Endosurgery, Inc.
APEN
-7,105
Closed -$11K
SIOX
5213
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$0 ﹤0.01%
15
-850
-98% -$2.81K
QTT
5214
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
$0 ﹤0.01%
+10
New +$288
MYOV
5215
DELISTED
Myovant Sciences Ltd.
MYOV
-18,387
Closed -$379K
SFT
5216
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
-91
Closed -$12K
CAJ
5217
DELISTED
Canon, Inc.
CAJ
-3,517
Closed -$70K
ELVT
5218
DELISTED
Elevate Credit, Inc.
ELVT
-15,135
Closed -$22K
IRL
5219
DELISTED
NEW IRELAND FUND INC
IRL
$0 ﹤0.01%
+5
New +$42
CNNB
5220
DELISTED
CINCINNATI BANCORP
CNNB
-1,556
Closed -$14K
HYRE
5221
DELISTED
HyreCar Inc. Common Stock
HYRE
-1,221
Closed -$4K
AYLA
5222
DELISTED
Ayala Pharmaceuticals, Inc. Common Stock
AYLA
-3,403
Closed -$34K
AVCT
5223
DELISTED
American Virtual Cloud Technologies, Inc. Common Stock
AVCT
-138
Closed -$7K
PRTY
5224
DELISTED
Party City Holdco Inc.
PRTY
-23,535
Closed -$35K
STAB
5225
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
-142
Closed

Similar funds

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.